Back

Present and the future of PCSK9 inhibition in cardiovascular prevention: from antibodies to gene editing - discussion

30 August 2026 (18:18 - 18:30)
Organised by: Logo
Congress Presentation Part of: Present and the future of PCSK9 inhibition in cardiovascular prevention: from antibodies to gene editing Risk Factors and Prevention ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

4 More presentations in this session

Presentation thumbnail
The discovery of PCSK9
Professor C. Boileau (Paris, FR)
Slides Video
Presentation thumbnail
The present: antibodies siRNAs
Professor K. Ray (London, GB)
Slides Video
Presentation thumbnail
Oral PCSK9 inhibitors
Doctor C. Ballantyne (Houston, US)
Slides Video
Presentation thumbnail
The future: gene editing
Professor A. Zeiher (Frankfurt, DE)
Slides Video

Access the full session

Session thumbnail
Present and the future of PCSK9 inhibition in cardiovascular prevention: from antibodies to gene editing
Video

The Event

Event poster

ESC Congress 2026

30 August 2026 18:18 CET
You may be interested in
thumbnail
Congress Presentation
Innovative prevention strategies: long-acting siRNA therapy - discussion
28 August 2026
thumbnail
Congress Presentation
PCSK9 inhibition: new insights
1 September 2024
thumbnail
Congress Presentation
New targets for lipid-lowering and atherosclerosis: what's beyond low-density lipoprotein? - discussion
30 August 2026
thumbnail
Congress Presentation
Discussion.
26 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources